Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
This is not a financial advice!
A few block buys and passive stakes recently
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 1.35, 1.55, 1.85, 3.0, 5.5, 6.8, levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 0.90
TP approx. midterm 3.0 if we fill the gap 8.0
Most info on the chart.
Trade carefully!
This is not a financial advice!
A few block buys and passive stakes recently
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 1.35, 1.55, 1.85, 3.0, 5.5, 6.8, levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 0.90
TP approx. midterm 3.0 if we fill the gap 8.0
Most info on the chart.
Trade carefully!
Block Trade: GOSS 599,000 @ $1.35 at the ask
Block Trade: GOSS 771,236 @ $1.35 at the ask